News|Articles|April 7, 2014

Dalton Pharma Completes Aseptic Filling Capabilities Expansion

Author(s)Pharmaceutical Technology Editors

Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.

Dalton Pharma Services

, a privately owned pharmaceutical services provider, reported the completion of a $2.5 million expansion of its sterile and aseptic filling capabilities in Toronto, Canada. This project included addition ofsterile vial processing and washing, expanded vial depyrogenation capability, automated vial inspection capability, a new Water For Injection (WFI) system, and expanded and improved gowning areas for GMP manufacturing operators.

Source:

Dalton Pharma Services

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.